Hematology & Blood Cancer
Hematology & Blood Cancer
Advertisement
Laura LitwinLeukemia | July 17, 2025
Chemotherapy is the main treatment for leukemia, with the potential to increase patient survival to 5 years or longer.
Read More
Laura LitwinLeukemia | July 17, 2025
The study explored if allogeneic HSCT to treat AML is equitably accessible regardless of social determinants of health.
Laura LitwinLeukemia | July 17, 2025
Allogeneic HSCT has substantially improved outcomes for patients impacted by aggressive hematologic malignancies.
Josie Montegaard, NPLeukemia | June 26, 2025
Josie Montegaard, NP, shares insights on how nurses can help patients manage their mental health during CLL treatment.
Josie Montegaard, NPLeukemia | June 25, 2025
Josie Montegaard, NP, discusses key developments in the field of CLL and how they will innovate the treatment landscape.
Cancer Nursing Today EditorsLeukemia | June 17, 2025
The program evaluated the practicality of independent pharmacists and nurses monitoring patients on a targeted-based regimen.
Cancer Nursing Today EditorsLeukemia | June 17, 2025
According to a team of researchers from China, family resilience could hold the key to boosting quality of life.
Cancer Nursing Today EditorsLeukemia | June 17, 2025
Understanding the relationship between caregiver burden and patient hope is essential, according to the researchers.
Cecilia BrownMultiple Myeloma | May 21, 2025
A series of semi-structured interviews revealed a “unique and burdensome” symptom experience among these patients.
Cecilia BrownMultiple Myeloma | May 21, 2025
The nurse-led team of researchers evaluated health information seeking behaviors across socioeconomic status groups.
Josie Montegaard, NPLeukemia | April 3, 2025
Josie Montegaard, NP, shares how nurses can help patients mitigate and manage negative CLL treatment side effects.
Laura LitwinConferences | June 10, 2025
Researchers analyzed clinical outcomes because hematopoietic SCT is becoming more a more accessible and utilized treatment.
Cecilia BrownConferences | June 10, 2025
Research presented at the NCCN Annual Conference illuminated patient experiences with tyrosine kinase inhibitors.
Laura LitwinConferences | June 10, 2025
Researchers assessed the cost effectiveness of ibrutinib, acalabrutinib, and zanubrutinib in multiple treatment settings.
Laura LitwinConferences | March 28, 2025
Researchers investigated underlying drivers of HRQOL degradation in CLL, including muscle weakness and fatigue.
Amy Pierre, RN, BSN, ANP-BCMultiple Myeloma | May 27, 2025
Amy Pierre, RN, BSN, ANP-BC, shares her insights on the importance of Multiple Myeloma Awareness Month.
Josie Montegaard, NPLeukemia | March 14, 2025
Josie Montegaard, NP, discusses key guidelines, criteria, and the need for flexibility when initiating treatment for CLL.
Laura LitwinGVHD | March 12, 2025
Previous research showed a potential connection between obesity and moderate to severe GVHD post-allogeneic SCT.
Stephen R. SpellmanConferences | March 6, 2025
Learn how ACCESS study data is informing patient-centered GVHD care and eliminating the donor access barrier for HSCT trials.
Josie Montegaard, NPLeukemia | February 28, 2025
Josie Montegaard, NP, shares how the right treatment timing and approach can influence quality of life for patients with CLL.
Advertisement
Advertisement